Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Company announcement – No. 9 / 2022 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in...
-
Company Announcement – No. 8 / 2022 Zealand Pharma convenes its Annual General Meeting 2022 Copenhagen, 10 March, 2022 – Zealand Pharma A/S (the "Company") convenes the Annual General Meeting of...
-
Company announcement – No. 7 / 2022Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in...
-
Company announcement – No. 6 / 2022 Zealand Pharma Hosts Conference Call on March 10 at 4 pm CET (10am ET) to Present Full Year Results for 2021 Copenhagen, DK and Boston, MA,...
-
Company announcement – No. 5 / 2022 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2022 Copenhagen, DK and Boston, MA, February 25, 2022 – Zealand Pharma A/S...
-
Company announcement – No. 4 / 2022 Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI) Top-line results expected in the...
-
Company announcement – No. 3 / 2022 Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome Full trial results of EASE-SBS 1...
-
Company announcement – No. 2 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, January 2022 Copenhagen, DK and Boston, MA, January 19, 2022 – Zealand Pharma A/S...
-
Company announcement – No. 1 / 2022 Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference Copenhagen, DK and Boston, MA, U.S. January 3, 2022 – Zealand Pharma A/S (Nasdaq:...
-
Company announcement – No. 78 / 2021 Total number of shares and voting rights in Zealand Pharma at December 30, 2021 Copenhagen, DK and Boston, MA, December 30, 2021 – Zealand Pharma A/S (“Zealand”)...